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status and health preferences were collected longitudi-
nally over three different time periods by the SF-36 and
the linear analog instruments. Only patients with chronic
diseases (n  5000) were included in the present study. A
moving average time series model was made using the
SF-36 components as explanatory variables and the lin-
ear analog scale as the dependent variable. Patient’s age,
gender, comorbidities, and health behavior were used as
covariates. As chronic disease severity may affect perceived
health status and health preference, two different cross-
sections were obtained on basis of high or low chronic
disease score. A random coefficient panel data model was
then used to capture heterogeneity. Model heteroscedas-
ticity was corrected by GARCH modification.
RESULTS: Domains of the SF-36 explained almost 49%
variation in the linear analog scale (Yule Walker estimate
R2  0.5055). All of the domains except “role limitation
due to emotional problem” showed high statistical signif-
icance level (p  0.05) in determining variation in the
LAS. Patient comorbidity also showed statistical signifi-
cance at the same level. Random coefficient model could
not find any statistically significant differences in estima-
tion procedure between patients with high and low num-
bers of chronic diseases. However, education and marital
status were significant predictors.
CONCLUSION: This study extends previous research to
derive a preference based index from the SF-36. This evi-
dence suggests that the SF-36 domains, education, and
marital status are better predictors of the LAS than is se-
verity of chronic disease.
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In spring 1998, the ERIQA project was launched with
the objective of producing guidelines on the use of QoL
data in the drug approval process. A first step led to a
thorough review of existing information.
OBJECTIVE: The purpose of the present study was to re-
view and evaluate the EMEA guidelines, to identify dis-
eases/drugs in which a formal QoL assessment is recom-
mended, identify measures and methods recommended,
and evaluate the reliability of recommendations across
documents.
METHODS: Four types of documents were retrieved in
the EMEA Web site (October 26,1998): notes for guid-
ance, concept papers, position papers, points to consider.
A first review allowed the selection of 105 documents.
The review of titles (by two independent reviewers) led to
the identification of 45 documents likely to contain QoL
recommendations.
RESULTS: Out of these 45 papers, only 12 showed ex-
plicit statements on QoL assessment. There are no docu-
ments directly focused on QoL measures, and few (11)
explicit recommendations on specific diseases/drugs.
QoL measures are often recommended as supportive cri-
teria of efficacy, except in COPD where it is considered
as a primary endpoint. There is only one example with
recommendations regarding dimensions to be included
(cardiac failure); only two questionnaires are cited (Min-
nesota Living with Heart Failure, St. George’s Respira-
tory Questionnaires); there are no comments on the issue
of generic/specific instruments, and no recommendations
in expected diseases/drugs (i.e., hypertension).
CONCLUSION: Our review showed that QoL is not for-
mally recognized as a criterion of evaluation by the EMEA,
and recommendations are not consistent across documents.
Further collaboration between regulatory bodies and QoL
researchers is needed to improve the quality of recommen-
dations.
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OBJECTIVE: To compare the performance of a generic
measure (EuroQoL EQ-5D) and condition-specific mea-
sures (GHQ-12, HADS, and SCL-90) in measuring men-
tal health outcomes.
METHODS: Patients from three separate studies were
identified: 1) dental patients attending for treatment (n 
600); 2) psychiatric patients taking part in an RCT of
psychotherapy (n  104); and 3) patients in an observa-
tional study in rheumatoid arthritis (RA) (n  233). Pa-
tients receiving dental treatment also complete the GHQ-12
(a measure of psychiatric “caseness”). Psychiatric patients
in the interventional study were assessed using SCL-90 at
baseline and again at 3 and 6 months. RA patients com-
pleted HADS at baseline, 3 months, and 12 months. All
patients completed EQ-5D on one or more occasions.
The performance of EQ-5D was tested in terms of its ca-
pacity to discriminate between groups with known differ-
ences in mental health status, and to detect significant
clinical change over time.
RESULTS: Dental patients who screened positive on the
GHQ-12 differed significantly in terms of their EQ-5D
from patients who did not. RA patients with well sepa-
rated HAD scores were found to differ significantly in
terms of EQ-5D. In the psychotherapy study, patients
with poor levels of general health status on admission re-
ported significant improvement; above average patients
reported significant deterioration. Correlation between
EQ-5D and SCL-90 subscales was significant.
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CONCLUSIONS: EQ-5D detects significant differences
in health status between patients with known mental
health problems, and is sensitive to changes in patients
with diagnosed mental illness. However, the anxiety/de-
pression dimension may have different sensitivity to its
two components.
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OBJECTIVES: The purpose of this study was to deter-
mine if order of completion of the Asthma Quality of Life
Questionnaire (AQLQ) and the Short-Form 36 (SF-36)
affected responses to domain or summary scores.
METHODS: A double-blind, randomized cost-effective-
ness trial compared triamcinolone 800 g per day versus
placebo in adult asthmatics over 12 months. Within the
clinical trial, 124 patients were randomized at the base-
line visit to one of two groups in which the order of the
self-administered health status questionnaires was alter-
nated. The first group received the AQLQ followed by
the SF-36 (N  63), and the second group was reversed
(N  61). Scores from the eight domains of the SF-36
and the four domains of the AQLQ were compared be-
tween the two groups. The groups were also compared
with regard to the overall quality of life score from the
AQLQ and the two summary scales from the SF-36.
RESULTS: The two groups did not differ significantly in
any of the domain scores, SF-36 summary scores, or the to-
tal score on the AQLQ. The overall quality of life score
from the AQLQ was 4.566 in the group that received the
AQLQ first and 4.702 in the SF-36 first group (p  0.500).
The summary estimates for the physical component sum-
mary scale (PCS) were 75.0 for the AQLQ first group and
74.1 for the SF-36 first group (p  0.589). The mental
health component summary scale (MCS) estimates were
74.3 versus 73.7 (p  0.711) for the respective groups.
CONCLUSION: The order in which questionnaires were
administered did not affect the domain or component
scores on the generic or disease specific health status
measures.
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About 270,000 surgeries for total or partial hip replace-
ment are performed annually in the United States. Pa-
tients not receiving prophylaxis agents result in an unac-
ceptably high incidence of deep vein thrombosis (DVT)
and pulmonary embolism (PE). The primary agents used
to prevent these complications are warfarin and low mo-
lecular weight heparins.
OBJECTIVES: This study examined the cost and out-
comes of hip surgery patients seen at Graduate Hospital
from October 1994 to September 1995.
METHODS: Economic and clinical outcomes data were
collected respectively for patients undergoing hip surgery
at Graduate Hospital in Philadelphia. The data were ana-
lyzed utilizing a risk adjusted outcome program devel-
oped for the Corporate Hospital Rating Project. Direct
costs were calculated using Medicare cost reporting data
by the hospital’s finance department.
RESULTS: Fifty-three patients were analyzed. Four re-
ceived both enoxaparin and warfarin, one received nei-
ther. These patients were excluded from the analysis. Re-
sults indicate the total direct cost ($6860 versus $10,320),
LOS (6.6d versus 10.5d) and complication rate (39.6%
versus 50.7%) were lower with warfarin versus enox-
aparin. Risk adjusted data also favored warfarin. There
was no evidence of DVT or PE in either group during the
6-month follow-up period after discharge.
CONCLUSIONS: The purported advantages of enox-
aparin over warfarin were not seen in our institution.
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Although postsurgical adhesions following general abdomi-
nal surgery are directly responsible for negative clinical out-
comes that require additional medical management and sur-
gical re-intervention (and concomitant costs), the magnitude
of these outcomes is not readily understood. Previous stud-
ies have been primarily case series in academic centers.
OBJECTIVE: We sought to establish the incidence of small-
bowel obstruction, adhesiolysis for obstruction, and addi-
tional abdominal surgery following open colorectal and
general surgery among the elderly across all settings.
METHODS: We conducted a retrospective cohort study
using patient-specific HCFA data to evaluate a random
5% sample of all Medicare patients undergoing surgery
in 1993. Of these, 18,912 patients had an index abdomi-
nal procedure. Two-year follow-up data documented
outcomes of hospitalizations with obstruction, adhesioly-
sis for obstruction, and/or additional open colorectal or
general surgery.
